Page 2 of 2 FirstFirst 12
Results 11 to 19 of 19

Thread: Help Regarding CANCER Treatment and Curing - for Information and help

  1. #11
    FK Citizen Canada man's Avatar
    Join Date
    Jun 2015
    Location
    Toronto ,canada
    Posts
    8,012

    Default


    Njan pharmaceutical research il anu joli cheyyunnathu,so enikku ariyavunna karayangal parayam,cancer spread cheyyathennu ningal paranjathil ninnu manasilayi,chemotherapy il ano eppol cheyyunnathu ,ethu drug anu chemo therapy il use cheyyunnathennu ariyamo
    Adayar cancer institute vare pokenda avasyam undennu thonnunnilla unless going for complex surgery or some thing like targeted radiation which is available there ,one of my cousin have cancer recently he is under treatment in Amrita . If cancer is in the last stage only one thing is possible ,extend the life by drugs.i mean chemo therapy.lot of new drugs are now available which may be very costly.kerala government is giving only generic drugs for free.which are old off patent drugs . Cancer effective aya Ayurvedic drugs illa .

  2. Sponsored Links ::::::::::::::::::::Remove adverts
  3. #12
    FK Big B Bilalikka Rules's Avatar
    Join Date
    Dec 2013
    Location
    Kochi ; Clt ; Tvm
    Posts
    22,250

    Default

    @Devarajan Master ENthenkilum Information Provide Cheyaan Patum


  4. Likes Madhavanunni liked this post
  5. #13
    FK Citizen Canada man's Avatar
    Join Date
    Jun 2015
    Location
    Toronto ,canada
    Posts
    8,012

    Default

    Cancer drugs approved this year in USA after successfull clinical trails 2015
    Cotellic (cobimetinib) ; Genentech; For the treatment of BRAF V600E or V600K melanoma, Approved November 2015

    Farydak (panobinostat); Novartis; For the treatment of multiple myeloma, Approved February 2015

    Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

    Imlygic (talimogene laherparepvec) ; Amgen; For the treatment of unresectable recurrent melanoma, Approved October 2015

    Lenvima (lenvatinib); Eisai; For the treatment of thyroid cancer, Approved February 2015

    Lonsurf (trifluridine and tipiracil); Taiho Oncology; For the treatment of metastatic colorectal cancer , Approved September 2015

    Odomzo (sonidegib); Novartis; For the treatment of locally advanced basal cell carcinoma, July 2015

    Onivyde (irinotecan liposome injection); Merrimack; For the treatment of metastatic pancreatic cancer following gemcitabine-based therapy, Approved October 2015

    Opdivo (nivolumab); Bristol-Myers Squibb; For the treatment of metastatic squamous non-small cell lung cancer, Approved March 2015

    Tagrisso (osimertinib); AstraZeneca; For the treatment of EGFR T790M mutation positive non-small cell lung cancer , Approved November 2015

    Unituxin (dinutuximab); United Therapeutics; For the treatment of pediatrics with high-risk neuroblastoma, Approved March 2015

    Varubi (rolapitant); Tesaro; For the prevention of delayed nausea and vomiting associated with chemotherapy, Approved September 2015

    Yondelis (trabectedin); Janssen; For the treatment of liposarcoma or leiomyosarcoma, Approved October 2015

  6. Likes josemon17, ClubAns liked this post
  7. #14
    FK Visitor lodestar's Avatar
    Join Date
    May 2009
    Location
    Trichur
    Posts
    373

    Default

    Quote Originally Posted by Canada man View Post
    Cancer drugs approved this year in USA after successfull clinical trails 2015
    Cotellic (cobimetinib) ; Genentech; For the treatment of BRAF V600E or V600K melanoma, Approved November 2015

    Farydak (panobinostat); Novartis; For the treatment of multiple myeloma, Approved February 2015

    Ibrance (palbociclib); Pfizer; For the treatment of ER-positive, HER2-negative breast cancer, Approved February 2015

    Imlygic (talimogene laherparepvec) ; Amgen; For the treatment of unresectable recurrent melanoma, Approved October 2015

    Lenvima (lenvatinib); Eisai; For the treatment of thyroid cancer, Approved February 2015

    Lonsurf (trifluridine and tipiracil); Taiho Oncology; For the treatment of metastatic colorectal cancer , Approved September 2015

    Odomzo (sonidegib); Novartis; For the treatment of locally advanced basal cell carcinoma, July 2015

    Onivyde (irinotecan liposome injection); Merrimack; For the treatment of metastatic pancreatic cancer following gemcitabine-based therapy, Approved October 2015

    Opdivo (nivolumab); Bristol-Myers Squibb; For the treatment of metastatic squamous non-small cell lung cancer, Approved March 2015

    Tagrisso (osimertinib); AstraZeneca; For the treatment of EGFR T790M mutation positive non-small cell lung cancer , Approved November 2015

    Unituxin (dinutuximab); United Therapeutics; For the treatment of pediatrics with high-risk neuroblastoma, Approved March 2015

    Varubi (rolapitant); Tesaro; For the prevention of delayed nausea and vomiting associated with chemotherapy, Approved September 2015

    Yondelis (trabectedin); Janssen; For the treatment of liposarcoma or leiomyosarcoma, Approved October 2015

    Thank u canada man... good info


  8. #15
    FK Citizen Canada man's Avatar
    Join Date
    Jun 2015
    Location
    Toronto ,canada
    Posts
    8,012

    Default

    Latest for lung cancer ,but just in ,not sure if available in india or not ,very costly

    AstraZeneca's just-approved lung cancer therapy Tagrisso will cost around $150,000 per year at wholesale acquisition prices in the US, according to the firm.
    Tagrisso (omisertinib; formerly AZD9291) bagged an early FDA approval on Friday for the treatment epidermal growth factor receptor (EGFR) positive non-small cell lung cancer (NSCLC) patients whose tumours carry the T790M mutation.
    The drug is a third-generation EGFR inhibitor, which is designed to overcome resistance to other drugs in the class such as Roche/Astellas' $2bn-a-year Tarceva (erlotinib), AZ's Iressa (gefitinib) and Boehringer Ingelheim's Giotrif (afatinib).
    It is the first drug to be approved for marketing in patients with T790M-positive NSCLC who have progressed on or after EGFR inhibitor therapy.
    A fifth of patients with NSCLC have tumours that are resistant to first-generation EGFR inhibitors from the outset, and the effects tend to be short-lived even in responders. Nearly all tumours eventually develop resistance within 10 to 12 months, even when switched to second generation drug Giotrif.
    The $12,750 per month cost of the third-generation EGFR inhibitor seems in line with the hefty price tags being attached to most of new lung cancer drugs, including ALK inhibitors such as Pfizer's Xalkori (crizotinib) and Novartis' Zykadia (ceritinib), according to a Reuters report.
    AZ has high hopes for Tagrisso, predicting it will eventually become a $3bn-a-year product, thanks to the high incidence of lung cancer and the fact that many patients taking EGFR-based therapy will eventually be eligible for treatment.
    All told, nearly two-thirds of NSCLC patients who are EGFR mutation-positive and experience disease progression after being treated with an EGFR inhibitor develop the T790M resistance mutation.
    Clovis setback

  9. #16

    Default

    Quote Originally Posted by chandru View Post
    I don't believe in the "miracle cure" of lada vaidyanas/ muri vaidyans..they r just exploiting the helplessness of desperate victims..
    Neither do I believe in kapada-sanyasis. In the case of Swami Nirmalanadagiri, he is an authority in Ayurveda and my personal experience is what I am vouching on.

    Quote Originally Posted by lodestar View Post
    Thanks a lot SKV.... Will go for it after meeting Dr.gangadharan of Lakeshore
    Yes. definitely meet Dr. Gangadharan..... and take all diagnosis documentation when visiting Swami Nirmalanandagiri
    - skv

  10. Likes ClubAns liked this post
  11. #17
    Kochi Rajavu samsha22's Avatar
    Join Date
    Aug 2008
    Location
    Bangalore
    Posts
    14,015

    Default

    problem with cancer is each case is unique (discovery channeil kandatha). each patient has a unique disease with its own nuclear structure unlike other virus/bacteria. athu kondanu generalize aayitulla medicines kondu ithine treat cheyyan pattathath. ithinu oru nalla treatment kandu pidikkum ennu ashikunnu...

    ex member/mod sagar aliar jackey oru oncologist aayirunnu

  12. #18

    Default

    @DEVaragan master

  13. #19

    Default

    ithu genuine aano ennariyilla...netil kandatha...

    ഷിമോഗ-സാഗര്* റൂട്ടില്* ആനന്ദപുരി ബസ് സ്റ്റോപ്പില്* നിന്ന് അഞ്ചു കിലോമീറ്റര്* അകലെ ശിക്കാരിപുര റൂട്ടില്* നരസിപുര എന്ന സ്ഥലത്തു. നാരായണ മൂര്*ത്തി എന്നാണു വൈദ്യരുടെ പേര്. ഞായര്*, വ്യാഴം ദിവസങ്ങളിലാണു മരുന്നു വിതരണം ചെയ്യുന്നത്. പ്രാഥമിക സൗകര്യങ്ങള്* പോലുമില്ലാത്ത കുഗ്രാമമാണത്.
    മരുന്നു വാങ്ങാന്* തലേന്നു തന്നെ ഉത്തരേന്ത്യയില്* നിന്നടക്കം രോഗികള്* എത്തുന്നുണ്ട്. ക്യാന്*സര്*, വൃക്കരോഗം, പ്രമേഹം തുടങ്ങിയവക്കെല്ലാം ചികില്*സിക്കുന്നു. മരുന്നു കഴിക്കുന്ന കാലത്തു കഠിനമായ പഥ്യമുണ്ട്. എരുവ്, പുളി, ചായ, കാപ്പി, എണ്ണയില്* വറുത്തത് (കടുകു വറുത്തതും പപ്പടവുമടക്കം) തുടങ്ങിയവയെല്ലാം ഒഴിവാക്കിയാണു ഞാന്* ജീവിച്ചത്. പലപ്പോഴും ചോറും തൈരുമായിരുന്നു. പക്ഷേ ഇന്നെനിക്കെല്ലാം കഴിക്കാം.
    ഗൂഗിളില്* narasipura narayana murthy എന്നോ cancer treatment in shimoga എന്നോ cancer treatment in narasipura എന്നോ ഒക്കെ ടൈപ്പ് ചെയ്ത് സെര്*ച്ച് ചെയ്താല്* കൂടുതല്* വിവരങ്ങള്* ലഭിക്കും. എന്റെ ഫോണ്* നമ്പര്*: 9447399372

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •